茜素黄R钠盐 ,sodium 5-[(4-nitrophenyl)azo]salicylate
产品编号:Bellancom-B413764| CAS NO:1718-34-9| 分子式:C13H8N3NaO5| 分子量:309.2095
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
产品名称 | 茜素黄R钠盐 |
---|---|
英文名称 | sodium 5-[(4-nitrophenyl)azo]salicylate |
CAS编号 | 1718-34-9 |
产品熔点 | 253-254 °C |
产品沸点 | 500.2ºC at 760 mmHg |
产品密度 | 1.49 g/cm3 |
产品闪点 | 256.3ºC |
精确质量 | 309.036163 |
PSA | 130.90000 |
LogP | 2.60250 |
溶解性 | soluble |
稳定性 | Stable. Incompatible with strong oxidizing agents, strong reducing agents. |
储存条件 | 1.密封于干燥处保存。 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
危害码 (欧洲) | Xn: Harmful; |
---|---|
风险声明 (欧洲) | R22 |
安全声明 (欧洲) | S24/25 |
海关编码 | 2942000000 |
Synonym:Alizarian Yellow R Sodium Salt; 5-(P-Nitrophenylazo) Salicylic Acid Sodium Salt; Sodium P-Nitrobenzeneazosalicylate Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Not available. Potential Health Effects Eye: May cause eye irritation. Skin: May cause skin irritation. Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated. Inhalation: May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Chronic: No information found. Section 4 - FIRST AID MEASURES Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists. Ingestion: Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: For small fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam. For large fires, use dry chemical, carbon dioxide, alcohol-resistant foam, or water spray. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Do not get in eyes, on skin, or on clothing. Do not ingest or inhale. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 1718-34-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: brown yellow, red brown or brown Odor: Odorless pH: Not available. Vapor Pressure: Negligible Viscosity: Not available. Boiling Point: Decomposes Freezing/Melting Point: 482 deg F Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Not available. Solubility in water: Soluble in water Specific Gravity/Density: >1.0 Molecular Formula: 4NO2C6H4N2C6H3C3Na1203H3 Molecular Weight: 635.1811 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials, dust generation, excess heat. Incompatibilities with Other Materials: Strong oxidizing agents Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide. Hazardous Polymerization: Has not been reported. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 1718-34-9: DH2528600 LD50/LC50: Not available. Carcinogenicity: Alizarin Yellow R Sodium Salt - Not listed by ACGIH, IARC, or NTP. Other: See actual entry in RTECS for complete information. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: WGK (Water Danger/Protection) CAS# 1718-34-9: No information available. Canada CAS# 1718-34-9 is listed on Canada's DSL List. CAS# 1718-34-9 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 1718-34-9 is listed on the TSCA inventory. SECTION 16 - ADDITIONAL INFORMATION N/A |